Stay updated on Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial

Sign up to get notified when there's something new on the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide NIH notice about updated terminology during a website transition appears above the study record.
    Difference
    1%
    Check dated 2026-10-24T15:08:26.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:46:00.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1 while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T15:44:12.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The study results view displays a 403 Forbidden error and a Home link instead of study results.
    Difference
    0.5%
    Check dated 2026-10-03T15:40:01.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The study results page now displays a 403 Forbidden error, replacing the usual study results view with a generic error page. This blocks access to the trial's results and related details.
    Difference
    6%
    Check dated 2026-09-19T19:33:13.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.6.6 is now displayed, replacing Revision: v3.6.5. This indicates a minor site version update to the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-08-29T19:42:16.000Z thumbnail image

Stay in the know with updates to Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page.